VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Helke who wrote (5216)	6/26/1998 5:07:00 PM
From: Dav!d	of 9719

Hello Andreas, Sorry but Entremed is at least 6 months away from any major news. Biotech stocks are short term trades becuase of the lag time between news releases. This stock closed at $30 and change which broke the technical (short-term) support of $31 1/2 (or so). I believe it will continue to slide, escpecially when it breaks the psychological $30 level. I see support at $27 first and then the second support at $23. NOTE: If they had any significant news to release don't you think they would have released it at the AGM? Hmmm. Great long term stock because of their Thalidamide drug and possibly positive results from the canine studies with angiostatin and endostatin. Just my opinion, david

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next